bio

Ella Zhang, the head of YZi Labs, stated at the Consensus 2026 conference that YZi Labs, in collaboration with Zhao Changpeng, currently manages over $10 billion in funds, focusing on investments in AI, biotechnology, and the Web3 space. Their investment logic adheres to first principles, concentrating on real needs rather than trends. AI is an inevitable trend, biotechnology presents an exponential opportunity to enhance human capabilities, while the cryptocurrency industry has cyclical characteristics.In addition to providing financial support, YZi Labs emphasizes cultivating resilient founders through a mentorship system. Furthermore, it was mentioned that stablecoins are the first key application for cryptocurrencies to go mainstream, and Zhao Changpeng is currently serving as a mentor with an "intern" mindset.

According to Binance spot market data, there has been significant volatility in the market. BIFI has increased by 15.34% in the last 24 hours and has shown a rebound after hitting a low. Meanwhile, STORJ has decreased by 13.16% in the last 24 hours and has shown a pullback after reaching a high.In addition, BIO has also shown a "pullback after reaching a high" status, with a 24-hour decrease of 13.11%; BANK has a 24-hour decrease of 13.3%, also showing a "pullback after reaching a high" status. Other tokens such as CHZ, IO, and SPK have performed relatively steadily, either reaching new highs today or experiencing slight declines.

According to monitoring by onchainschool.pro, the FBG Capital wallet deposited approximately $700,000 worth of BIO (15 million tokens) to Binance last night. A portion of the BIO was previously received from the team's unlocked wallet. Currently, there are still 14.9 million BIO tokens remaining in that wallet.

Binance will delist the following spot trading pairs on December 26, 2025, at 11:00: BIO/FDUSD, ENS/FDUSD, INJ/ETH, TREE/BNB, and VTHO/TRY. Users can still trade the underlying assets and quoted assets on other trading pairs. Please note that Binance will also remove the trading bot services for the above trading pairs, and it is recommended that users disable the related services in advance.

Tether participated in a €70 million (approximately $80 million) funding round for Italy's Generative Bionics. The company was spun off from the Italian Institute of Technology and focuses on developing "physical AI" humanoid robots that can operate in high-risk or high-load industrial environments, aiming to perform handling, dragging, and repetitive tasks that traditional robotic arms struggle with.Tether CEO Paolo Ardoino stated that this investment is an important step for the company in its strategy towards "digital and physical infrastructure," aiming to reduce reliance on centralized systems from large tech companies and support technological innovations that can enhance societal resilience. In recent years, Tether has invested in several internal and external AI projects and has multiple investments in the Bitcoin mining sector. A few weeks before this announcement, S&P Global had downgraded the stability rating of USDT, citing increased exposure of Tether to Bitcoin and other assets with lower transparency. Tether promptly rebutted that the rating system is "outdated."Generative Bionics indicated that its first industrial deployments are expected to take place in early 2026, targeting industries including manufacturing, logistics, healthcare, and retail. Additionally, the Financial Times previously reported that Tether is also in talks to invest in the German startup Neura Robotics, which is valued at around $10 billion.

According to The Block, stablecoin issuer Tether, along with AMD Ventures, the Italian state-backed AI fund, and other investors, participated in a €70 million (approximately $81.48 million) funding round for the newly spun-off generative bionics company from the Italian Institute of Technology.The one-year-old company is developing "embodied artificial intelligence" industrial humanoid robots designed to operate in environments built for humans, capable of performing handling, towing, and repetitive tasks that traditional robotic arms struggle to execute easily. CEO Paolo Ardoino stated that this investment is part of what he describes as a shift towards supporting "digital and physical infrastructure," projects that expand the company's business landscape beyond stablecoins and reduce its "dependency" on an increasingly centralized system under the regulation of large tech companies. Generative Bionics announced that its first industrial deployments are scheduled to launch in early 2026, targeting industries including manufacturing, logistics, healthcare, and retail.

YZi Labs announced the full list of founders and companies for the second season of EASY Residency during Binance Blockchain Week, where these teams will showcase their innovative projects on Demo Day.This season focuses on the intersection of three major fields: Web3, AI, and biotechnology, demonstrating the potential for technological convergence over the next decade. Selected projects include 42.space, 4D Labs, AllScale, Advent, AgriDynamics, among others, covering various directions such as prediction markets, 3D data, cross-border payments, gene therapy, and agricultural robotics.

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

According to on-chain analyst Yu Jin's monitoring, after unlocking and receiving 12.212 million BIO (730,000 USD) from the BIO attribution contract, BitMEX co-founder Arthur Hayes transferred 19.872 million BIO (1.2 million USD) to Binance one hour ago.

According to on-chain analysis platform Lookonchain, Arthur Hayes deposited 7.66 million BIO tokens into Binance, worth approximately $460,000.This batch of BIO tokens was withdrawn from Binance 3 months ago when the price of BIO was $0.144. At the current price, Arthur Hayes has an unrealized loss of $640,000 on this investment, a decline of 58%.

According to official news, YZi Labs announced an investment in the regenerative medicine company Renewal Bio, marking YZi Labs' first biotechnology investment since expanding its investment scope in early 2025.Renewal Bio focuses on using its proprietary Stembroid™ platform to generate human cells and tissues that are DNA-matched to patients from their own cells, aiming to address the global organ shortage crisis. Over 150,000 organ transplants are performed worldwide each year, but less than 10% of the demand is met. Renewal Bio reprograms ordinary skin or blood cells into stem cells by simulating the early human developmental environment, generating various functional cells, including hematopoietic, liver, heart, and pancreatic cells.The company was co-founded in 2022 by Professor Jacob Hanna from the Weizmann Institute of Science and his two PhD students, Vladislav Krupalnik and Ohad Gafni. This round of financing will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for the treatment of leukemia and immune diseases, and support the expansion of laboratory infrastructure.

Binance founder Changpeng Zhao stated on social media regarding community rumors that "Beyond Borders" is his autobiography, saying, "This is not a book I wrote. Please be cautious of those who use artificial intelligence for scams."

The French eBook and audiobook platform Vivlio has launched Zhao Changpeng's autobiography "Beyond Borders," with the page indicating that the first edition date is November 9, 2025, and the eBook price is free.

According to market news, digital asset finance company Propanc Biopharma (NASDAQ: PPCB) announced on Monday that it has secured up to $100 million in financing from family office Hexstone Capital, which is active in the fields of Bitcoin, Ethereum, Solana, Dogecoin, and other digital assets.The private placement transaction is structured through convertible preferred stock, with Propanc receiving an initial investment of $1 million and up to $99 million in follow-on funding over the next year. The proceeds will be used to build Propanc's digital asset portfolio and accelerate the development of its lead oncology therapy, PRP, which is currently planned to begin its first human trials in 2026. CEO James Nathanielsz described this move as a "transformational phase," aimed at strengthening the company's balance sheet and providing funding support for its enzyme-based research projects. The company did not specify which digital assets it plans to acquire. The financing news did not stop the decline in Propanc's stock price. On Monday, PPCB's stock fell 4%, dropping below $1, with a cumulative decline of 43% over the past month.

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.

According to GlobeNewswire, Trust Stamp (NASDAQ: IDAI) has announced the launch of a cryptocurrency and asset tokenization program, with its core product being the biometric verification digital asset wallet, TSI Wallet.The wallet is set to officially launch on January 1, 2026, and the waitlist opened for registration on October 24. TSI Wallet utilizes user facial biometric technology to generate a proprietary Stable Key, eliminating the need to remember passwords or private keys, and can be used as a single asset wallet or a "wallet within a wallet."The wallet features tamper-proof capabilities, meaning that even if data is leaked, attackers cannot exploit it, as biometric data is stored in shards and does not contain private key information.Trust Stamp CEO Gareth N. Genner stated that with the market capitalization of stablecoins reaching approximately $227 billion and quarterly trading volumes exceeding $1 trillion, the company expects TSI Wallet to make a significant contribution to revenue starting in Q4 2026.

ChainCatcher news, according to Decrypt, the biotech defense startup Valthos has raised $30 million in funding from the OpenAI Startup Fund, Lux Capital, and Founders Fund.The AI system developed by the company can update medical responses based on the speed of biological threats, enabling researchers and government agencies to identify and respond to pathogens as quickly as possible.Valthos was founded in November last year in New York, and its leaders include: former Palantir Technologies life sciences head Kathleen McMahon, former Oxford University computational neuroscience researcher Tess van Stekelenburg, and founding AI engineer Victor Mao (who previously served as a research engineer at Google DeepMind).